Recently, several new small-molecule inhibitors targeting the nucleotide-sanitizing enzyme MTH1 (TH287, TH588 and S-crizotinib) were described to specifically induce lethality in a broad spectrum of cancer cells without harming untransformed tissues [12–14]. This evidence concerns the gene NUDT1 and cancer.